The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia: Feasibility and Early Outcomes
Abstract
CONTEXT: The Zambian Ministry of Health has scaled-up human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) care and treatment services at primary care clinics in Lusaka, using predominately nonphysician clinicians. OBJECTIVE: To report on the feasibility and early outcomes of the program. DESIGN, SETTING, AND PATIENTS: Open cohort evaluation of antiretroviral-naive adults treated at 18 primary care facilities between April 26, 2004, and November 5, 2005. Data were entered in real time into an electronic patient tracking system. INTERVENTION: Those meeting criteria for antiretroviral therapy (ART) received drugs according to Zambian national guidelines. MAIN OUTCOME MEASURES: Survival, regimen failure rates, and CD4 cell response. RESULTS: We enrolled 21,755 adults into HIV care, and 16,198 (75%) started ART. Among those starting ART, 9864 (61%) were women. Of 15,866 patients with documented World Health Organization (WHO) staging, 11,573 (73%) were stage III or IV, and the mean (SD) entry CD4 cell count among the 15,336 patients with a baseline result was 143/microL (123/microL). Of 1142 patients receiving ART who died, 1120 had a reliable date of death. Of these patients, 792 (71%) died within 90 days of starting therapy (early mortality rate: 26 per 100 patient-years), and 328 (29%) died after 90 days (post-90-day mortality rate: 5.0 per 100 patient-years). In multivariable analysis, mortality was strongly associated with CD4 cell count between 50/microL and 199/microL (adjusted hazard ratio [AHR], 1.4; 95% confidence interval [CI], 1.0-2.0), CD4 cell count less than 50/microL (AHR, 2.2; 95% CI, 1.5-3.1), WHO stage III disease (AHR, 1.8; 95% CI, 1.3-2.4), WHO stage IV disease (AHR, 2.9; 95% CI, 2.0-4.3), low body mass index (<16; AHR,2.4; 95% CI, 1.8-3.2), severe anemia (<8.0 g/dL; AHR, 3.1; 95% CI, 2.3-4.0), and poor adherence to therapy (AHR, 2.9; 95% CI, 2.2-3.9). Of 11,714 patients at risk, 861 failed therapy by clinical criteria (rate, 13 per 100 patient-years). The mean (SD) CD4 cell count increase was 175/microL (174/microL) in 1361 of 1519 patients (90%) receiving treatment long enough to have a 12-month repeat. CONCLUSION: Massive scale-up of HIV and AIDS treatment services with good clinical outcomes is feasible in primary care settings in sub-Saharan Africa. Most mortality occurs early, suggesting that earlier diagnosis and treatment may improve outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Survival analysis using sas®: a practical guide
Allison, P. D. (1995) · International Linear Collider · Cited by 3,609
Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes
McNutt, L.-A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg074 · Cited by 2,096
Lucas, G. M., Chaisson, R. E., & Moore, R. D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-2-199907200-00002 · Cited by 843
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., Reuter, H., Ntwana, N., & Goemaere, E. (2004) · AIDS · doi:10.1097/00002030-200404090-00006 · Cited by 584
Curran, J. W., Debas, H. T., Arya, M., Kelley, P., Knobler, S., & Pray, L. A. (2005) · Cited by 534
Ferradini, L., Jeannin, A., Pinoges, L., Izopet, J., Odhiambo, D., Mankhambo, L., Karungi, G., Szumilin, E., Balandine, S., Fedida, G., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68580-2 · Cited by 450
A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality
Fawzi, W. W., Msamanga, G. I., Spiegelman, D., Wei, R., Kapiga, S., Villamor, E., Mwakagile, D., Mugusi, F., Hertzmark, E., Essex, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040541 · Cited by 446
Grabar, S., Moing, V. L., Goujard, C., Leport, C., Kazatchkine, M. D., Costagliola, D., & Weiss, L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00007 · Cited by 414
DeSimone, J. A., Pomerantz, R. J., & Babinchak, T. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00013 · Cited by 383
Weidle, P. J., Malamba, S., Mwebaze, R., Sozi, C., Rukundo, G., Downing, R., Hanson, D., Ochola, D., Mugyenyi, P., Mermin, J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09330-3 · Cited by 315
Scaling up access to antiretroviral treatment in southern Africa: who will do the job?
Kober, K., & Van Damme, W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16597-5 · Cited by 244
Grossberg, R., Zhang, Y., & Gross, R. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.002 · Cited by 189
Nutrition and HIV/AIDS in sub-Saharan Africa: An overview
Anabwani, G. M., & Navario, P. (2005) · Nutrition · doi:10.1016/j.nut.2004.09.013 · Cited by 108
Hirsch, M., Steigbigel, R. T., Staszewski, S., Mellors, J. W., Scerpella, E. G., Hirschel, B. J., Lange, J. M. A., Squires, K., Rawlins, S., Meibohm, A. R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314948 · Cited by 102
Cozzi‐Lepri, A., Phillips, A. N., Monforte, A. D., Piersantelli, N., Orani, A., Petrosillo, N., Leoncini, F., Scerbo, A., Tundo, P., Abrescia, N., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339821 · Cited by 91
Fairley, C. K., Permana, A., & Read, T. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00322.x · Cited by 79
Adrenal Function in the Human Immunodeficiency Virus–Infected Patient
Mayo, J., Collazos, J., Martínez, E., & Ibarra, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1095 · Cited by 74
Perneger, T. V., Sudre, P., Lundgren, J. D., et al. (1995) · BMJ · doi:10.1136/bmj.311.7018.1468 · Cited by 61
Leroy, V., Salmi, L., Dupon, M., Sentilhes, A., Texier-Maugein, J., Dequae, L., Dabis, F., Salamon, R., & (GECSA), G. D. C. D. S. E. A. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009105 · Cited by 55
Kitchen, C. M., Kitchen, S. G., Dubin, J. A., & Gottlieb, M. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321900 · Cited by 50
Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis
Harries, A. D., Libamba, E., Schouten, E. J., Mwansambo, A., Salaniponi, F. M. L., & Mpazanje, R. (2004) · BMJ · doi:10.1136/bmj.329.7475.1163 · Cited by 47
Chi, B. H., Sinkala, M., Stringer, E. M., McFarlane, Y., Nguni, C. M., Myzece, E., Goldenberg, R. L., & Stringer, J. S. A. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000159515.39982.c0 · Cited by 8
Self-citation
Cited by
Wang, H., Liddell, C. A., Coates, M. M., Mooney, M. D., Levitz, C. E., Schumacher, A. E., Apfel, H., Iannarone, M., Phillips, B., Lofgren, K. T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60497-9 · Cited by 799
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830007cd · Cited by 639
An assessment of interactions between global health initiatives and country health systems
(2009) · The Lancet · doi:10.1016/s0140-6736(09)60919-3 · Cited by 511
Brinkhof, M. W. G., Pujades-Rodriguez, M., & Egger, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005790 · Cited by 482
Metadata
- Authors
- Stringer, J. S. A., Zulu, I., Levy, J., Stringer, E. M., Mwango, A., Chi, B. H., Mtonga, V., Reid, S., Cantrell, R. A., Bulterys, M., Saag, M. S., Marlink, R. G., Mwinga, A., Ellerbrock, T. V., & Sinkala, M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-08-16
- Volume
- 296
- Issue
- 7
- Pages
- 782
- ISSN
- 0098-7484
- OpenAlex
- W2163477848
- Cited by
- 655
- References
- 24
- FWCI
- 38.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.